Hep C Virus - Hepatitis B and C -- familydoctor.org

Hepatitis B and C -- familydoctor.org
What are chronic hepatitis B and chronic hepatitis C? ... Hepatitis B and hepatitis C are spread by contact with infected blood or other body fluids of ...

Hepatitis C: Fact Sheet | CDC Viral Hepatitis
There is no vaccine to prevent hepatitis C. Do not shoot drugs; ... Hepatitis C. HCV positive persons should be evaluated by their doctor for liver disease. ...

VA National Hepatitis C Program
The Veterans Affairs National Hepatitis C Web site provides information about viral hepatitis for health care providers inside and outside the VA system, ...

Hepatitis C
NEW: The Hepatitis C Sourcebook. By Howard J. Worman, MD. The Hepatitis C Virus (HCV). HCV was discovered in 1989 by investigators at Chiron, Inc. Portions ...

Hep C Virus - Daily Planner: Monday

Daily Planner: Monday
Enterprise-Record, CA - Apr 3, 2006... Call for an appointment. Weekly. HEP C/STD TESTING: 8 am to 5 pm Fee or free depending on eligibility. Butte County Public Health Department: Chico clinic,. ...

Weekender Calendar
Fitchburg Sentinel, MA - Apr 6, 2006... North Worcester County AIDS Service Coordination Collaborative presents "Doctor says: You've got Hep C, what do I do now?" Keynote speaker is Nancy Cote, BSN ...

Gossip World: A secret TomKat Scientology wedding, a baby Trump a ...
The Free Lance-Star, VA - Mar 23, 2006... When you walk around barefoot, you increase your chances of stepping on a needle discarded by a heroin addict and contracting Hep C. ...

Novartis Seen 'Saving Face' With Idenix Hep C Deal
Forbes - Mar 29, 2006... a research report Wednesday. "We think NM283 will make it to market and become a competitive hep C player.". Idenix shares fell 28 ...

Needle exchange made possible
Merritt Herald, Canada - Mar 29, 2006... "For me this is a ministry of humanity and a small way that we can be involved in the prevention of the spread of Hep C and HIV.". ...

Hep C Virus - Hepatitis C: The Test

Hepatitis C: The Test
Hepatitis C. The Test. How is it used? Each of the five most common tests has a slightly different purpose: Anti-HCV tests detect the presence of antibodies to the virus, indicating exposure to HCV.

HCV - Wikipedia, the free encyclopedia
... Your continued donations keep Wikipedia running! HCV. From Wikipedia, the free encyclopedia ... to change the link to point directly to the intended article. HCV may mean the following ...

HCV Hepatitis Anonymous - 12 Steps - Home Page - Hep C Virus - 12 Steps & Meetings
HCV Hepatitis Anonymous supplies current hepatitis news & information on Hepatitis C (HCV), 12 steps, big book, positive attitudes, online HCV meetings and live chat!! ... Living with HCV--Self-Help Tips ... These are a few of the Herbs that have been associated with liver disease and NOT recommended for those with HCV ...

Hep C Virus - Antibodies Neutralizing Peginterferon Alfa during Retreatment of

Antibodies Neutralizing Peginterferon Alfa during Retreatment of
New England Journal of Medicine - To the Editor: Peginterferons are widely used to treat chronic hepatitis C virus (HCV) infection, an important cause of liver cirrhosis and hepatocellular carcinoma. 1 , 2 , 3 , 4 We describe a patient who did not have a virologic response to

Hepatitis C Market: Plenty Of Potential, But Little Progress
Investors Business Daily - The month of March was not kind to a pair of companies racing to find a cure or vaccine for hepatitis C, the often fatal liver disease that's been called a global epidemic by the World Health Organization. On March 21, Valeant Pharmaceuticals ( VRX

Cuban Combined Therapy Against Chronic Hepatitis C
Ahora.cu - A Cuban combination therapy for the treatment of chronic Hepatitis C is to be put on the market by the Heber Biotec S.A. company in Latin America, Asia, Africa, the Middle East and Europe, where this firm has registered the Heberon Alfa R (human

Hepatitis Still a Frustrating Foe
Street.Com - Since March 14, three drugmakers, Human Genome Sciences ( HGSI :Nasdaq - news - research - Cramer's Take ), Idenix Pharmaceuticals ( IDIX :Nasdaq - news - research - Cramer's Take ) and Valeant Pharmaceuticals ( VRX :NYSE - news - research - Cramer's

Hep C Virus - The Body: Viral Hepatitis C

The Body: Viral Hepatitis C
Viral Hepatitis C, at The Body, the complete HIV/AIDS resource.

Chronic Viral Hepatitis
Viral Hepatitis C: Formerly known as "non-A, non-B Hepatitis." This form of viral hepatitis is the most common. It can be spread through blood transfusions ...

Viral Hepatitis Fact Sheet
Fact sheet on viral hepatitis. ... Australian Government - Department of Health and Ageing. Sitemap | AZ Index | Links | Contact Us | Calendar | Site Help ...

Hepatitis C: Index | CDC Viral Hepatitis
Viral hepatitis C Prevention for Injection Drug Users Abobe (external link*); What Every Injection Drug User Should Know (brochure) Abobe; Viral Hepatitis ...

Hep C Virus - World J Gastroenterol

World J Gastroenterol
Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. World J Gastroenterol 2002 October ...

Australia antigen and heaptitis: a review.
Journal List > J Clin Pathol > v.24(5); Jul 1971. >>> Summary. Page Browse. References. PDF ( 1.8 M ). Contents. Archive. Related material : ...

Nurses Update
View as HTMLCoinfection HIV & Viral Heaptitis: a. guide. December 2003. Third Edition. Produced in Association with the Australian Liver ...

Observation of lipid profile and lipoproteins in viral hepatitis ...
VLDL levels were significantly decreased in patients of viral heaptitis (22.13 �8 mg/dl) as well as on viral hepatitis with coma (21.89 �3 mg/dl). ...

Hep C Virus - Hepatitis C

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Activists: Hepatitis C clinical trial unfairly excludes blacks
shared by mfeed Advocate - Two advocacy groups are blasting the decision by pharmaceutical company Schering-Plough to exclude African-Americans from a clinical trial of its experimental hepatitis C treatment, a decision the company says was needed to better gauge the efficacy ...... Read more... blink it

Conclusions About Milk Thistle
A May 2005 review of clinical studies which casts doubt on milk thistle's value has recently been re-released into the press. Alternatively, an extensive amount of research supports the continued usage of this herb at higher dosages. Researchers of the...

Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

Hep C Virus - Doctor: Getting the Most from Your Doctor s Appointment

Doctor: Getting the Most from Your Doctor s Appointment
Title: Doctor: Getting the Most from Your Doctor s AppointmentCategory: Doctor's ViewsCreated: 5/13/2005Last Editorial Review: 5/13/2005

Conclusions About Milk Thistle
A May 2005 review of clinical studies which casts doubt on milk thistle's value has recently been re-released into the press. Alternatively, an extensive amount of research supports the continued usage of this herb at higher dosages. Researchers of the...

Google Toolbar Button: BlinkBits
Share What You Know, Discover What You Dont on ANYTHING from Anywhere by adding the BlinkBits to your Google Toolbar. Share to any blink, bookmark any page, see what others are sharing on all the blinks, click blink it on stories you like to increase its relevancy and more.

Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM

Hep C Virus - World War II Exhibition

World War II Exhibition
Nantucket Inquirer and Mirror - Mar 09 11:57 AM
10 a.m.-4 p.m. in the Whitney Gallery, Nantucket Historical Association Research Library, 7 Fair St. An exhibition of 30 hand-colored photographs of Nantucketers on the eve of their involvement in World War II. The gallery is open 10 a.m.-4 p.m. Mondays, Tuesdays, Thursdays and Fridays.Save to My Web

Drug Users' Hard Lessons Become Tools to Teach Doctors
New York Times - Apr 01 11:18 PM
In the Albert Einstein College of Medicine's residency program at Montefiore Medical Center, substance abuse training may include lessons from those with firsthand experience.Save to My Web

Schering-Plough, PTC Therapeutics team up for development of PTC's preclinical hep C compounds
PharmaBiz - Mar 21 9:43 PM
Schering-Plough Corporation and PTC Therapeutics, Inc. (PTC) have entered into an exclusive collaboration and licensing agreement for the development of PTC's preclinical compounds for the oral treatment of hepatitis C virus (HCV) infection and other viral diseases.Save to My Web

Novartis Licenses Hep C Drug
Red Herring - Mar 29 1:24 PM
The Swiss pharmaceutical giant agrees to co-promote Idenix experimental hepatitis C drug.Save to My Web

Hep C Virus - VX-950 To Get Fast Tracked

VX-950 To Get Fast Tracked
As you may recall we've been saying VX-950 is the revolutionary new therapy to watch for HCV. Now it looks like the FDA agrees this treatment is quite promising and deserving of faster approval than a lesser worthy approach. Another...

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

Liver Blood Tests
Title: Liver Blood TestsCategory: Procedures and TestsCreated: 6/2/1998Last Editorial Review: 8/27/2005

A Breakthrough Discovery for Hepatitis C
The state of Florida has recently produced a study illuminating the replication and mutation of the Hepatitis C virus. This kind of progress represents a giant leap forward in tracking this persistent virus, which likely means more accurate and efficient...

Hep C Virus - Schering-Plough and PTC Therapeutics Announce Collaboration for Development of PTC's Preclinical Hepatitis C Compounds

Schering-Plough and PTC Therapeutics Announce Collaboration for Development of PTC's Preclinical Hepatitis C Compounds
[Press Release] PR Newswire via Yahoo! Finance - Mar 20 5:30 AM
Schering-Plough Corporation and PTC Therapeutics, Inc. today announced that they have entered into an exclusive collaboration and licensing agreement for the development of PTC's preclinical compounds for the oral treatment of hepatitis C virus infection and other viral diseases.Save to My Web

NOVARTIS announces in-licensing of valopicitabine (NM283), a novel first-in- ...
Financial.de - Mar 28 11:21 PM
Basel, Switzerland, March 29, 2006 - Novartis ( News / Kurs / Chart / Board ) announced today that it has exercised its option from Idenix Pharmaceuticals to in-license the late-stage development compound valopicitabine (NM283) for the treatment of hepatitis C, a condition estimated to affect more than 170 million people worldwide and a major cause of liver disease.Save to My Web

Chinese Patients With Chronic Hepatitis B Respond Better To Telbivudine Than Lamivudine
Medical News Today - Mar 27 4:05 PM
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) and Novartis (NYSE: NVS) todayannounced new data that demonstrate telbivudine, an investigational oral,once-daily nucleoside analogue, provided significantly greater antiviral andclinical efficacy in Chinese patients with chronic hepatitis B (CHB) afterone-year of treatment when compared with a current standard of care,lamivudine... click link for more Save to My Web

ViRexx Announces Collaboration with Defence Research and Development Canada-Suffield to Expand Chimigen'TM' Platform
[Press Release] Business Wire via Yahoo! Finance - Mar 31 5:00 AM
EDMONTON, Alberta----March 31, 2006--ViRexx Medical Corp. , a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumors, today announced that it has entered into a research collaboration with Defence Research and Development Canada - Suffield to carry out research on applying ViRexx's proprietary Chimigen vaccine platform for Save to My Web

XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2005
FinanzNachrichten - Mar 20 11:08 AM
NEW YORK, March 20 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals, ( Nachrichten ) Ltd. , a biotechnology company focused on the acquisition, development and commercialization of therapeutics for the treatment of infectious diseases, with a focus on hepatitis C, today announced its financial results for year ended December 31, 2005.Save to My Web